Cited 1 times in
KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이용주 | - |
dc.date.accessioned | 2023-04-20T08:20:03Z | - |
dc.date.available | 2023-04-20T08:20:03Z | - |
dc.date.issued | 2023-01 | - |
dc.identifier.issn | 2092-7355 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194067 | - |
dc.description.abstract | The prevalence of allergic rhinitis (AR) and the socioeconomic burden associated with the medical cost and quality of life (QOL) of AR have progressively increased. Therefore, practical guidelines for the appropriate management of AR need to be developed based on scientific evidence while considering the real-world environment, values, and preferences of patients and physicians. The Korean Academy of Asthma, Allergy and Clinical Immunology revised clinical guidelines of AR to address key clinical questions of the management of AR. Part 1 of the revised guideline covers the pharmacological management of patients with AR in Korea. Through a meta-analysis and systematic review, we made 4 recommendations for AR pharmacotherapy, including intranasal corticosteroid (INCS)/intranasal antihistamine (INAH) combination therapy, oral antihistamine/INCS combination therapy, leukotriene receptor antagonist treatment in AR patients with asthma, and prophylactic treatment for patients with pollen-induced AR. However, all recommendations are conditional because of the low or very low evidence of certainty. Well-designed and strictly executed randomized controlled trials are needed to measure and report appropriate outcomes. Copyright © 2023 The Korean Academy of Asthma, Allergy and Clinical Immunology. | - |
dc.description.statementOfResponsibility | open | - |
dc.publisher | Korean Academy of Pediatric Allergy and Respiratory Disease | - |
dc.relation.isPartOf | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Pediatrics (소아과학교실) | - |
dc.contributor.googleauthor | Song-I Yang | - |
dc.contributor.googleauthor | Il Hwan Lee | - |
dc.contributor.googleauthor | Minji Kim | - |
dc.contributor.googleauthor | Gwanghui Ryu | - |
dc.contributor.googleauthor | Sung-Yoon Kang | - |
dc.contributor.googleauthor | Mi-Ae Kim | - |
dc.contributor.googleauthor | Sang Min Lee | - |
dc.contributor.googleauthor | Hyun-Jung Kim | - |
dc.contributor.googleauthor | Do-Yang Park | - |
dc.contributor.googleauthor | Yong Ju Lee | - |
dc.contributor.googleauthor | Dong-Kyu Kim | - |
dc.contributor.googleauthor | Soo Whan Kim | - |
dc.contributor.googleauthor | Do Hyun Kim | - |
dc.contributor.googleauthor | Young Joon Jun | - |
dc.contributor.googleauthor | Sang Chul Park | - |
dc.contributor.googleauthor | Bong-Seong Kim | - |
dc.contributor.googleauthor | Soo Jie Chung | - |
dc.contributor.googleauthor | Hyun Jong Lee | - |
dc.contributor.googleauthor | Hyo-Bin Kim | - |
dc.contributor.googleauthor | Jeong-Hee Choi | - |
dc.contributor.googleauthor | Gil-Soon Choi | - |
dc.contributor.googleauthor | Hyeon-Jong Yang | - |
dc.identifier.doi | 10.4168/aair.2023.15.1.19 | - |
dc.contributor.localId | A02983 | - |
dc.relation.journalcode | J00064 | - |
dc.identifier.eissn | 2092-7363 | - |
dc.identifier.pmid | 36693355 | - |
dc.subject.keyword | Rhinitis, allergic | - |
dc.subject.keyword | asthma | - |
dc.subject.keyword | drug therapy | - |
dc.subject.keyword | guideline | - |
dc.contributor.alternativeName | Lee, Yong Ju | - |
dc.contributor.affiliatedAuthor | 이용주 | - |
dc.citation.volume | 15 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 19 | - |
dc.citation.endPage | 31 | - |
dc.identifier.bibliographicCitation | ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, Vol.15(1) : 19-31, 2023-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.